GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 6.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -50.0% | 11,470 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $8,000 | -55.6% | 11,470 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $18,000 | -14.3% | 11,470 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $21,000 | -34.4% | 11,470 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $32,000 | -8.6% | 11,470 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $35,000 | – | 11,470 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |